You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Inhibitors-GC-14
GC-14

Chemical Structure : GC-14

CAS No.: 2768834-39-3

GC-14

Catalog No.: PC-49342Not For Human Use, Lab Use Only.

GC-14 is a potent, selective and non-covalent non-peptide SARS-CoV-2 main protease (Mpro) inhibitor with IC50 of 0.4 uM, displays excellent selectivity over cathepsins B, F, K, L, and caspase 3 (IC50>50 uM).

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GC-14 is a potent, selective and non-covalent non-peptide SARS-CoV-2 main protease (Mpro) inhibitor with IC50 of 0.4 uM, displays excellent selectivity over cathepsins B, F, K, L, and caspase 3 (IC50>50 uM).
GC-14 displays excellent antiviral activity (EC50 = 1.1 μM), being more potent than Remdesivir.
GC-14 exhibits low cytotoxicity (CC50>100 μM).
GC-14 occupys multiple subpockets by critical non-covalent interactions.

Physicochemical Properties

M.Wt 475.388
Formula C22H20Cl2N4O2S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-1-(3,4-dichlorophenyl)-4-nicotinoyl-N-(thiophen-2-ylmethyl)piperazine-2-carboxamide

References

1. Gao S, et al. J Med Chem. 2022 Sep 15. doi: 10.1021/acs.jmedchem.2c01146.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: